SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
1.132 |
Evidence |
|
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
1.132 |
Evidence |
|
EDA |
IPI00023765 |
TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
1.132 |
Evidence |
|
ARNT |
ARNT: Aryl hydrocarbon receptor nuclear translocator |
HES6 |
HES6: Transcription cofactor HES-6 |
1.132 |
Evidence |
|
TNFSF12 |
TNFSF13, APRIL, UNQ383/PRO715, TALL2, ZTNF2: Tumor necrosis factor ligand superf |
NGFR |
NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor |
1.132 |
Evidence |
|
FASLG |
FASLG, APT1LG1, FASL, TNFSF6: Tumor necrosis factor ligand superfamily member 6 |
EDAR |
EDAR, DL: Tumor necrosis factor receptor superfamily member EDAR precursor |
1.132 |
Evidence |
|
GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
HTR6 |
HTR6: 5-hydroxytryptamine receptor 6 |
1.132 |
Evidence |
|
CD40LG |
CD40LG, CD40L, TNFSF5, TRAP: CD40 ligand |
EDAR |
EDAR, DL: Tumor necrosis factor receptor superfamily member EDAR precursor |
1.132 |
Evidence |
|
AGT |
AGT, SERPINA8: Angiotensinogen precursor |
KLK3 |
KLK3, APS: Prostate-specific antigen precursor |
1.132 |
Evidence |
|
GNAS |
GNAS, GNAS1, GSP: Guanine nucleotide-binding protein G(s) subunit alpha isoforms |
TSHR |
IPI00386365 |
1.132 |
Evidence |
|
DRD2 |
DRD2: D(2) dopamine receptor |
GNAI1 |
GNAI1: Guanine nucleotide-binding protein G(i), alpha-1 subunit |
1.132 |
Evidence |
|
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
SYK |
SYK: Tyrosine-protein kinase SYK |
1.132 |
Evidence |
|
F11 |
F11: Coagulation factor XI precursor |
SERPINA3 |
IPI00550991 |
1.132 |
Evidence |
|
KCNH2 |
KCNH2, ERG, ERG1, HERG, HERG1: Potassium voltage-gated channel subfamily H membe |
TRPV1 |
TRPV1: Vanilloid receptor variant TRPV1b |
1.132 |
Evidence |
|
TNFRSF1B |
TNFRSF1B, TNFBR, TNFR2: Tumor necrosis factor receptor superfamily member 1B pre |
EDA |
IPI00023765 |
1.132 |
Evidence |
|
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
1.132 |
Evidence |
|
KLK3 |
KLK3, APS: Prostate-specific antigen precursor |
SERPINA3 |
IPI00550991 |
1.132 |
Evidence |
|
AZGP1 |
AZGP1, tcag7.638: Alpha-2-glycoprotein 1, zinc-binding |
HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
1.132 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
1.132 |
Evidence |
|
MAPK9 |
MAPK9, JNK2, PRKM9: Mitogen-activated protein kinase 9 |
DUSP3 |
DUSP3, VHR: Dual specificity protein phosphatase 3 |
1.132 |
Evidence |
|
IL6R |
IL6R: Interleukin-6 receptor alpha chain precursor |
IL2 |
IL2: Interleukin 2 |
1.132 |
Evidence |
|
TRPV1 |
TRPV1: Vanilloid receptor variant TRPV1b |
TRPC3 |
N-terminally extended type 3 canonical transient receptor potential channel |
1.132 |
Evidence |
|
CASP1 |
CASP1, IL1BC, IL1BCE: Caspase-1 precursor |
TRADD |
TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein |
1.132 |
Evidence |
|
PLAT |
PLAT: Tissue-type plasminogen activator precursor |
SERPINB4 |
SERPINB3, SCCA, SCCA1: Serpin B3 |
1.132 |
Evidence |
|
PTEN |
PTEN, MMAC1, TEP1: Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and du |
MAPK15 |
IPI00395861 |
1.132 |
Evidence |
|